CD8A and acute myeloid leukemia: Consistently, a recent paired analysis of single cell RNA and TCR repertoire profiling in relapsed/refractory AML demonstrated that TCR repertoires primarily from CD8+ cells expand in patients who responded to PD-1 treatment, but contract in those who were treatment resistant (165).